Aldeyra Therapeutics, Inc. (ALDX)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Basis of Presentation | — |
|
| Basis of Presentation and Significant Accounting Policies | — |
|
| Cash, Cash Equivalents and Marketable Securities | ||
| Commitments and Contingencies | ||
| Credit Facility | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Fair Value Measurements | ||
| Helio Vision Acquisition | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Leases | ||
| Nature of Business | ||
| Net Loss Per Share | ||
| Option Agreement | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Segment Reporting | ||
| Significant Agreements | ||
| Stock Incentive Plan | — |
|
| Stock-based Compensation | — |
|
| Stockholders' Equity | ||